KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Return on Assets (2016 - 2025)

Acadia Pharmaceuticals has reported Return on Assets over the past 15 years, most recently at 0.1% for Q4 2025.

  • Quarterly results put Return on Assets at 0.1% for Q4 2025, down 11.0% from a year ago — trailing twelve months through Dec 2025 was 0.1% (down 11.0% YoY), and the annual figure for FY2025 was 0.1%, down 13.0%.
  • Return on Assets for Q4 2025 was 0.1% at Acadia Pharmaceuticals, down from 0.2% in the prior quarter.
  • Over the last five years, Return on Assets for ACAD hit a ceiling of 0.21% in Q4 2024 and a floor of 0.36% in Q4 2022.
  • Median Return on Assets over the past 5 years was 0.2% (2023), compared with a mean of 0.11%.
  • Biggest five-year swings in Return on Assets: dropped -13bps in 2022 and later surged 37bps in 2024.
  • Acadia Pharmaceuticals' Return on Assets stood at 0.24% in 2021, then tumbled by -53bps to 0.36% in 2022, then skyrocketed by 76bps to 0.09% in 2023, then skyrocketed by 335bps to 0.21% in 2024, then tumbled by -54bps to 0.1% in 2025.
  • The last three reported values for Return on Assets were 0.1% (Q4 2025), 0.2% (Q3 2025), and 0.19% (Q2 2025) per Business Quant data.